Development and validation of a programmed cell death index to predict the prognosis and drug sensitivity of gastric cancer
The novel PCDI model shows significant potential in predicting clinical prognosis and drug sensitivity of GC, thereby facilitating personalized treatment strategies for patients with GC.
Authors
- Zhoukai Zhao
- Feiyang Zhang (ORCID: https://orcid.org/0000-0002-3746-9756)
- Zi‐Qi Zheng (ORCID: https://orcid.org/0009-0003-1495-5027)
- Ruopeng Zhang (ORCID: https://orcid.org/0000-0001-7677-4051)
- Shenghang Ruan
- Zewei Chen (ORCID: https://orcid.org/0000-0001-7758-7581)
- Run‐Cong Nie (ORCID: https://orcid.org/0000-0003-3595-6304)
- Xiaojiang Chen (ORCID: https://orcid.org/0000-0002-1180-6806)
- Yuan Li (ORCID: https://orcid.org/0000-0001-9809-9894)
- Yongming Chen (ORCID: https://orcid.org/0000-0003-2843-5543)
- Baiwei Zhao (ORCID: https://orcid.org/0009-0004-2125-8657)
- Guoming Chen (ORCID: https://orcid.org/0000-0002-2339-7368)
- Bowen Huang (ORCID: https://orcid.org/0000-0003-4588-659X)
- Chengcai Liang (ORCID: https://orcid.org/0000-0001-7625-4574)
- Feizhi Lin
- Chengzhi Wei
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.3389/fphar.2024.1477363
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00